In a study of 640 patients with psoriatic arthritis (PsA) from 13 countries, 37.7% reported severe pain and 45.6% reported severe fatigue after more than 3 months of treatment with TNF inhibitors, suggesting a need for improved disease management in PsA. Health-related quality of life and work productivity scores were worse in patients with moderate or severe pain or fatigue compared with those with low pain or fatigue. Mental health scores (self-reported happiness and the mental health domain of short form-36 v2) were also lowest in patients reporting the most severe pain or fatigue.
References
Original article
Conaghan, P. G. et al. Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study. RMD Open 6, e001240 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clarke, J. Pain and fatigue persist in PsA despite treatment. Nat Rev Rheumatol 16, 472 (2020). https://doi.org/10.1038/s41584-020-0478-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0478-1